Federal award
ACELRX PHARMACEUTICALS, INC.
W81XWH20C0133
Contract
Obligated and Ceiling
- Obligated (net)
- $935,237.20
- Ceiling (potential value, not spending)
- $3,570,235.20
- Current value
- $935,237.20
- Gross positive obligations
- $935,283.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ACELRX PHARMACEUTICALS, INC. · RS3UJNCL6YG1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ACELRX PHARMACEUTICALS, INC. · RS3UJNCL6YG1
- Awarding agency
- Department of War · sub-agency 97DH · office HT9425
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W81XWH20C0133
- Award type code
- D
- Actions
- 4 · Sep 20, 2020 to Jun 23, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 23, 2023 | FY2023 | P00003 | D | −$45.80 | — |
| Sep 15, 2022 | FY2022 | P00002 | B | $3,702.00 | — |
| Aug 19, 2021 | FY2021 | P00001 | B | $7,213.50 | — |
| Sep 20, 2020 | FY2020 | 0 | — | $924,367.50 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.